Page last updated: 2024-09-02

phorbol-12-myristate and Fatigue Syndrome, Chronic

phorbol-12-myristate has been researched along with Fatigue Syndrome, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huth, TK; Marshall-Gradisnik, S; Staines, D	1

Other Studies

1 other study(ies) available for phorbol-12-myristate and Fatigue Syndrome, Chronic

Article	Year
ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Journal of translational medicine, 2016, Apr-21, Volume: 14 Topics: Antigens, CD; Case-Control Studies; Cytokines; Cytotoxicity, Immunologic; Extracellular Signal-Regulated MAP Kinases; Fatigue Syndrome, Chronic; Humans; Ionomycin; Killer Cells, Natural; Lymphocyte Activation; Mitogen-Activated Protein Kinase Kinases; p38 Mitogen-Activated Protein Kinases; Phenotype; Phorbol Esters; Signal Transduction	2016

Article

Year

ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.

Journal of translational medicine, 2016, Apr-21, Volume: 14

Topics: Antigens, CD; Case-Control Studies; Cytokines; Cytotoxicity, Immunologic; Extracellular Signal-Regulated MAP Kinases; Fatigue Syndrome, Chronic; Humans; Ionomycin; Killer Cells, Natural; Lymphocyte Activation; Mitogen-Activated Protein Kinase Kinases; p38 Mitogen-Activated Protein Kinases; Phenotype; Phorbol Esters; Signal Transduction

2016